InsiderTrades

Form 4 for INSM INSMED Inc

Accepted 2025-01-31 00:00:00 ET · period of report 2025-01-30 · accession 0001628280-25-003322 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-01-31 2025-01-30 INSM Schaeffer Orlov S Nicole Chief People Strategy Off M - OptEx $15.04 +91.1K 188.2K +94% +$1.37M
D 2025-01-31 2025-01-30 INSM Schaeffer Orlov S Nicole Chief People Strategy Off S - Sale+OE $80.00 -91.1K 97.1K -48% -$7.29M
DM 2025-01-31 2025-01-30 INSM Schaeffer Orlov S Nicole Chief People Strategy Off M - OptEx $0.00 -91.1K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-01-30 M A 50,000 $16.16 147,083 D — —
2 Common Common Stock 2025-01-30 S D 91,140 $80.00 97,083 D — —
3 Common Common Stock 2025-01-30 M A 41,140 $13.67 188,223 D — —
4 Derivative Stock Option (right to buy) 2025-01-30 M D 41,140 $0.00 0 D $13.67 · — to 2027-01-05 41,140 Common Stock (F2) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.
5 Derivative Stock Option (right to buy) 2025-01-30 M D 50,000 $0.00 0 D $16.16 · — to 2026-01-07 50,000 Common Stock (F2) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.